We are delighted to announce that our clinical trial for our TIES implant has now been initiated at hospitals in the UK, Sweden, Poland, Austria and India.
With the TIES implant, we are aiming to transform the lives of people with an ileostoma and enable them to take back control of their lives.
The clinical trial will be crucial in establishing the safety and performance of the technology, as well as achieving regulatory approval for the device.
‘Initiating the clinical trial for our TIES implant is a crucial milestone for the development of the technology. The safety and performance data from the trial will enable us to secure regulatory approval for the device. We are incredibly grateful to the patients and clinical teams taking part’. Dr Johan Jarte, CEO, Ostomy Cure.Leave a reply